Tuesday, August 30, 2016

Grafton Public Library Announces 'ADHD Essentials Workshop' - Patch.com


Grafton Public Library Announces 'ADHD Essentials Workshop'
Patch.com
A contributing author to 365+1 Way to Succeed with ADHD and highly engaging speaker, Brendan addresses the emotional, academic and lifestyle impacts the disorder has on the lives of the people who have it, as well as those who love them. In his talks ...

Alcobra's (ADHD) CEO Yaron Daniely on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha


Alcobra's (ADHD) CEO Yaron Daniely on Q2 2016 Results - Earnings Call Transcript
Seeking Alpha
Good day ladies and gentlemen, and welcome to the Alcobra's Second Quarter 2016 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will ...

Healthy Living: Welcome Back to School: Does My Kid Have ADHD? - WABI


WABI

Healthy Living: Welcome Back to School: Does My Kid Have ADHD?
WABI
The school year is upon us. For some, the beginning of the school year can be a tough adjustment as the unstructured playland of summer has ended. Some children have more needs than others, but how can parents identify if their child has ADHD and then ...

and more »

Health Care Sector Update for 08/30/2016: RIGL,SKLN,ADHD - Nasdaq


Health Care Sector Update for 08/30/2016: RIGL,SKLN,ADHD
Nasdaq
ADHD, Reports Q2 net loss of $0.21 per share, missing Street view by $0.01 per share. The company did not have any revenue, as expected. Expects to complete enrollment for trial of MDX drug candidate in children with ADHD by Dec. 31 and release data ...

and more »

The ADHD Epidemic: Smart Drugs and the Control of Bodies and Minds - Truth-Out


The ADHD Epidemic: Smart Drugs and the Control of Bodies and Minds
Truth-Out
Attention Deficit Hyperactivity Disorder (ADHD), which has seen massive recent increases in diagnosis since 2000, is defined as a difficulty in paying attention, restlessness, and hyperactivity. By 2010, nearly one in three US children age 2-17 had ...

NLS Pharma Announces Start Of Its Phase 2 Trial For Mazindol In ... - PR Newswire (press release)


NLS Pharma Announces Start Of Its Phase 2 Trial For Mazindol In ...
PR Newswire (press release)
STANS, Switzerland, Aug. 29, 2016 /PRNewswire/ -- NLS Pharma Group (NLS) announced today that it has initiated enrollment for its "Double-Blind ...

and more »

Alcobra Ltd. (ADHD) Earns "Overweight" Rating from Piper Jaffray Cos. - BBNS


Alcobra Ltd. (ADHD) Earns "Overweight" Rating from Piper Jaffray Cos.
BBNS
Alcobra Ltd. (NASDAQ:ADHD)'s stock had its “overweight” rating reiterated by analysts at Piper Jaffray Cos. in a note issued to investors on Tuesday. ADHD has been the topic of a number of other research reports. Barclays PLC began coverage on shares ...
Alcobra Ltd. (ADHD) Issues Earnings ResultsThe Cerbat Gem
Alcobra Ltd. (NASDAQ:ADHD) Given Consensus Rating of "Buy" by AnalystsCommunity Financial News
Brokers Issue Average Price Target Of 13.93 On Alcobra Ltd. (ADHD)Fiscal Standard
Seneca Globe -Post News -Consumer Eagle
all 15 news articles »